DE LUCA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 18.199
EU - Europa 9.989
AS - Asia 9.274
SA - Sud America 1.211
AF - Africa 173
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 15
Totale 38.931
Nazione #
US - Stati Uniti d'America 17.979
GB - Regno Unito 4.074
SG - Singapore 2.737
CN - Cina 2.656
IT - Italia 1.962
HK - Hong Kong 1.360
BR - Brasile 945
SE - Svezia 857
VN - Vietnam 831
DE - Germania 625
FI - Finlandia 480
UA - Ucraina 453
TR - Turchia 366
FR - Francia 353
RU - Federazione Russa 319
KR - Corea 292
IN - India 193
BG - Bulgaria 168
SI - Slovenia 166
JP - Giappone 134
ID - Indonesia 125
NL - Olanda 121
CA - Canada 116
BD - Bangladesh 102
AR - Argentina 85
PL - Polonia 72
IQ - Iraq 65
MX - Messico 65
ZA - Sudafrica 62
AE - Emirati Arabi Uniti 51
ES - Italia 49
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 43
BE - Belgio 39
IR - Iran 39
CL - Cile 38
CO - Colombia 37
AT - Austria 36
AU - Australia 36
NZ - Nuova Zelanda 34
UZ - Uzbekistan 33
SA - Arabia Saudita 30
TW - Taiwan 30
PH - Filippine 29
CZ - Repubblica Ceca 27
LT - Lituania 27
MA - Marocco 26
EG - Egitto 22
MY - Malesia 22
VE - Venezuela 22
DK - Danimarca 20
RO - Romania 19
TH - Thailandia 17
DZ - Algeria 16
JO - Giordania 14
QA - Qatar 14
KE - Kenya 13
TN - Tunisia 13
CH - Svizzera 12
PT - Portogallo 12
PY - Paraguay 12
UY - Uruguay 12
IL - Israele 11
KZ - Kazakistan 11
PE - Perù 11
NP - Nepal 10
EU - Europa 9
AZ - Azerbaigian 8
AL - Albania 7
DO - Repubblica Dominicana 7
BY - Bielorussia 6
ET - Etiopia 6
HU - Ungheria 6
JM - Giamaica 6
KW - Kuwait 6
NI - Nicaragua 6
PS - Palestinian Territory 6
RS - Serbia 6
MD - Moldavia 5
OM - Oman 5
GR - Grecia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CG - Congo 3
CR - Costa Rica 3
HN - Honduras 3
KH - Cambogia 3
LB - Libano 3
LV - Lettonia 3
MN - Mongolia 3
PA - Panama 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 38.897
Città #
Southend 3.199
Santa Clara 1.763
Singapore 1.602
Fairfield 1.552
Ashburn 1.537
Hong Kong 1.334
Woodbridge 1.320
Chandler 1.029
Houston 995
Jacksonville 959
Hefei 772
San Jose 707
Dearborn 694
Ann Arbor 620
Wilmington 577
Cambridge 552
Seattle 550
Beijing 483
London 438
Nyköping 385
Helsinki 309
Los Angeles 305
The Dalles 279
Seoul 253
Ho Chi Minh City 249
Hanoi 212
Modena 210
Council Bluffs 195
San Diego 181
Izmir 180
Princeton 180
Chicago 171
Sofia 166
Milan 161
Eugene 151
Lauterbourg 140
New York 128
Des Moines 123
Rome 111
Bologna 102
Buffalo 101
Bari 99
Columbus 98
Moscow 96
Shanghai 87
Jakarta 86
São Paulo 83
Redwood City 82
Falls Church 81
Munich 78
Salt Lake City 68
Tokyo 64
Dallas 56
Boardman 49
Frankfurt am Main 46
Orem 45
Norwalk 44
Warsaw 40
Bremen 39
Dublin 38
Guangzhou 37
Haiphong 36
Kent 32
Elk Grove Village 30
Tampa 29
Auckland 28
Brasília 28
Brooklyn 28
Phoenix 28
Xi'an 28
Belo Horizonte 27
Brussels 27
Changsha 27
Chennai 27
Da Nang 27
Nanjing 27
Rio de Janeiro 27
Tashkent 27
Formigine 26
Paris 26
Baghdad 25
Reggio Emilia 25
Atlanta 24
Falkenstein 24
Glasgow 24
Johannesburg 23
Toronto 23
Amsterdam 22
Campinas 22
Dhaka 22
Kunming 21
Medesano 21
Turku 21
Catania 20
Mexico City 20
Montreal 20
Redondo Beach 20
Zhengzhou 20
Vienna 19
Denver 18
Totale 27.260
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 822
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 567
Holoclar: first of its kind in more ways than one 526
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 474
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 407
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 407
Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine 386
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 384
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 374
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 361
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 361
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 349
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 347
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 346
Advances in stem cell research and therapeutic development 328
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 326
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 321
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 321
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 312
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 311
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 304
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 300
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 297
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 295
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 293
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 292
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 292
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 291
The long and winding road that leads to a cure for epidermolysis bullosa 290
Chloride transport pathways in human keratinocytes 290
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 289
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 286
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 286
Gene therapy approaches for epidermolysis bullosa 284
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 283
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 275
A discussion on cell therapy in Manchester 274
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 273
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 271
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 271
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 270
Clonal analysis of human clonogenic keratinocytes 265
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 264
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 264
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 263
Stem cell plasticity: time for a reappraisal? 259
Corneal Bioengineering 259
Cell biology: Dormant and restless skin stem cells 256
Eyes on the prize: Limbal stem cells and corneal restoration 255
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 254
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 251
Characterization of chloride transport pathways in cultured human keratinocytes 250
Topography and biological role of integrins in human skin 247
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 247
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 245
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 244
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 242
Gene therapy of inherited skin adhesion disorders: a critical overview 241
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 239
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 239
Stamina therapies: Let the record stand 239
Towards a gene therapy clinical trial for epidermolysis bullosa 238
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 238
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 237
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 237
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 237
p63 identifies keratinocyte stem cells 236
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 235
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 233
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 231
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 231
Limbal stem-cell therapy and long-term corneal regeneration. 230
Regeneration of squamous epithelia from stem cells of cultured grafts 229
Structural and functional studies of integrin receptors in cultured human keratinocytes 228
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 228
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 226
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 225
Clonal analysis of stably transduced human epidermal stem cells in culture. 224
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 223
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 221
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 221
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 221
Advances on potential therapeutic options for epidermolysis bullosa 220
Towards therapeutic application of ocular stem cells 219
Stairways to Advanced Therapies for Epidermolysis Bullosa 216
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 216
CRYOPROTECTIVE AQUEOUS SOLUTIONS USEFUL FOR THE PRESERVATION OF IN VlTRO CULTURED EPITHELIAL SHEETS 216
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 215
Cultivation of human keratinocyte stem cells: current and future clinical applications 215
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 213
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 213
Toward gene therapy of junctional epidermolysis bullosa (JEB) 211
Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes 208
Culture of human epithelium 208
Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. 207
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 206
Transforming Growth-Factor (TGF)-Beta(1) Enhances Alpha(5)Beta(1) And Alpha(V)Beta(5) Integrin Expression And Migration Of Normal Human Keratinocytes 201
The control of polarized integrin topography and the organization of adhesion-related cytoskeleton in normal human keratinocytes depend upon number of passages in culture and ionic environment. 201
Corneal epithelial stem-cell transplantation 200
Totale 27.833
Categoria #
all - tutte 140.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.481 0 0 0 0 0 0 0 0 0 1.076 226 179
2021/20223.170 79 403 238 284 141 250 202 173 345 218 471 366
2022/20233.174 369 339 333 233 365 475 69 285 424 43 140 99
2023/20242.028 76 128 123 159 387 128 119 271 55 225 83 274
2024/20257.304 254 98 175 478 1.276 1.146 570 379 683 271 913 1.061
2025/202610.174 759 658 983 1.073 1.231 941 1.540 624 1.182 1.183 0 0
Totale 39.276